Supernus Pharmaceuticals SUPN
$ 34.67
2.06%
Quarterly report 2024-Q3
added 11-04-2024
Supernus Pharmaceuticals EV/EBITDA Ratio 2011-2024 | SUPN
Annual EV/EBITDA Ratio Supernus Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
19.1 | 8.48 | 8.97 | 13.6 | 18 | 21.1 | 27.5 | 13.9 | -5.12 | -2.83 | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
27.5 | -5.12 | 12.3 |